Why clinical trial outcomes fail to translate into benefits for patients

This is an excellent piece of commentary by Carl Heneghan and colleagues with the above title.

Open access: YES

Published: 14 Mar 2017

13063_2017_1870_Fig1_HTML.gif

Fig. 1 Why clinical trial outcomes fail to translate into benefits for patients

The authors listed the above reasons why clinical trials may fail to translate beneficially for patients in the clinic. And it covers a range of issues from design flaws to poor methodology, problems such as publication bias and poor interpretation of data.

And they go through each one of them in this article. It’s a great piece to enlighten us of the many limitations that a clinical trial may have, especially when they are not done well. As clinicians we need to be able to spot these limitations as we critically appraise journal articles so that we may accurately interpret the results of the study.

Please click on the link below to read the full article:

Heneghan, C. et al (2017) Why clinical trial outcomes fail to translate into benefits for patients. BioMed Central.

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s